ADVANCE Study

The ADVANCE Study at Yale is a treatment study examining the use of Varenicline (Chantix) to reduce alcohol consumption.

We are looking for heavy drinkers who smoke cigarettes and would like to reduce or stop drinking.

All treatment is strictly confidential and free of charge. If eligible, you can earn up to $525 for participating.

Click the links above to obtain more information regarding the Advance Study, and to see if you’re eligible.

How to participate

Call us:
203-859-8643

Take a web Survey:
Take a web survey to find out if you're eligible

If you would like us to contact you:
Provide your contact information on this short form

Email:
advance@yale.edu

Address:
1 Long Wharf Drive, SATU, Box 18, New Haven, CT, 06511

HIC #1106008598
Sponsored by the National Institutes of Health and Yale School of Medicine